An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
about
DNAVaxDB: the first web-based DNA vaccine database and its data analysis.An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeB7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal diseaseA wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread.A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.The challenge of developing a herpes simplex virus 2 vaccine.A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccineAntigenic breadth: a missing ingredient in HSV-2 subunit vaccines?Attenuated phenotypes and analysis of a herpes simplex virus 1 strain with partial deletion of the UL7, UL41 and LAT genes.
P2860
Q30841376-E2BEA453-B21D-4C31-9538-81424D862FDFQ33916162-6998E187-D304-45E9-AAB3-E04BE7D89FBFQ33985984-0CE9291E-362D-4260-AD20-52BD041211BCQ34055287-8DCE66D9-1483-4738-81DC-3518BAB5E213Q35867958-71F076AF-0FA3-4BEC-903A-0B17C5A87FAEQ36433844-997C8A86-3231-42A7-9FBD-69FCC5261D42Q36671106-5E901E69-AC32-4080-B794-0FCC5AAF9C15Q36845870-F22A24C7-729A-40B4-B0F5-35F176110E02Q37439603-D2543F5B-132A-427F-BC6F-B083715C02A3Q38212516-0CFCF8C5-D217-4AFD-86CE-A94800E84B2FQ41925774-E9CA61A0-A32D-4970-9114-88829062470B
P2860
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
@en
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
@nl
type
label
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
@en
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
@nl
prefLabel
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
@en
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
@nl
P2093
P2860
P1433
P1476
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
@en
P2093
Gary H Cohen
Harvey M Friedman
John M Lubinski
Sita Awasthi
P2860
P304
P356
10.1016/J.VACCINE.2007.12.032
P407
P577
2008-01-14T00:00:00Z